Synthesis and biological evalution of novel carboxylate phosphabetaines derivatives with long alkyl chains by Bakhtiyarova Yuliya Valerevna et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=gpss20
Download by: [178.205.215.228] Date: 30 August 2016, At: 06:26
Phosphorus, Sulfur, and Silicon and the Related Elements
ISSN: 1042-6507 (Print) 1563-5325 (Online) Journal homepage: http://www.tandfonline.com/loi/gpss20
Synthesis and Biological Evaluation of Novel
Carboxylate Phosphabetaines Derivatives with
Long Alkyl Chains
Irina V. Galkina, Alfiya F. Aksunova, Dmitriy I. Bakhtiyarov, Marina P.
Shulaeva, Oskar K. Pozdeev, Svetlana N. Egorova, Yuliya V. Bakhtiyarova &
Vladimir I. Galkin
To cite this article: Irina V. Galkina, Alfiya F. Aksunova, Dmitriy I. Bakhtiyarov, Marina P.
Shulaeva, Oskar K. Pozdeev, Svetlana N. Egorova, Yuliya V. Bakhtiyarova & Vladimir I. Galkin
(2016): Synthesis and Biological Evaluation of Novel Carboxylate Phosphabetaines Derivatives
with Long Alkyl Chains, Phosphorus, Sulfur, and Silicon and the Related Elements, DOI:
10.1080/10426507.2016.1227821
To link to this article:  http://dx.doi.org/10.1080/10426507.2016.1227821
Accepted author version posted online: 29
Aug 2016.
Published online: 29 Aug 2016.
Submit your article to this journal 
View related articles 
View Crossmark data
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 1 
Synthesis and Biological Evaluation of Novel Carboxylate Phosphabetaines Derivatives 
with Long Alkyl Chains 
Irina V. Galkina,
1
 Alfiya F. Aksunova,
1
 Dmitriy I. Bakhtiyarov,
1
 Marina P. Shulaeva,
2
  
Oskar K. Pozdeev,
2
 Svetlana N. Egorova,
2
 Yuliya V. Bakhtiyarova,
1
 Vladimir I. Galkin
1 
 
1
Kazan Federal University, Kazan, Russia.  
2
Kazan State Medical University, Kazan, Russia.  
 
Address correspondence to name Irina V. Galkina e-mail vig54@mail.ru  
 
GRAPHICAL ABSTRACT 
 
 
Abstract The purpose of the present study was to investigate the antibacterial activity of novel 
alkyl esters of carboxylate phosphabetaine: β-(carboxyalkyl)ethyltributylphosphonium bromides 
4-8. The in vitro microbiological activity of the synthesized phosphonium bromides against 
gram-positive, gram-negative bacteria and the yeast Candida albicans was determined in 
comparison to standard agents. Microbiological results indicate the synthesized phosphonium 
salts possess a broad spectrum of activity against the tested microorganisms. Every newly 
synthesized compound was characterized by elemental analyses, IR, 
1
H NMR, 
31
P NMR spectral 
studies. 
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INTRODUCTION 
 
Demand for new antimicrobial agents is high because more microorganisms develop 
resistance against drugs currently available on the market. Resistance of pathogenic bacteria to 
antibiotics is rapidly becoming a major problem in the medical community and hospital-based 
healthcare settings. The search for novel agents to combat resistant bacteria has become one of 
the most important areas of antibacterial research today
1,2
. Pharmaceutical and organic chemists 
are trying to synthesize new drugs with better pharmacokinetic and dynamic properties. We have 
earlier described the methods of preparation various phosphabetaines based on tertiary 
phosphines and unsaturated carboxylic acids and reported on their structure and reactivity
3-7
. 
In this study, we prepared tributyl-substituted phosphonium salts 4-8 on the basis of 
phosphabetaines (1) containing alkyl chains of various lengths. The synthesis of such 
phosphonium salts is more difficult in comparison with ammonium analogs
8,9
. Betaines easily 
react with alkyl halogenides with short alkyl chains to form the corresponding phosphonium salts 
without biological activity
10,11
. 
RESULTS AND DISCUSSION 
 
Chemistry 
 In this paper we present the synthesis and biological activity of a series of nanosized (30 
nm) quaternary phosphonium salts 4-8 with long alkyl chains (R = CnH2n+1; n = 10, 12, 14, 16 
18; here n is the number of carbon atoms in alkyl groups) on the basis of phosphabetaine 1 and 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 4 
higher alkyl halogenides. All the synthesized compounds were characterized by elemental 
analysis, IR, 
1
H NMR, and 
31
P NMR spectroscopy. The synthetic routes are given in Scheme 1. 
Scheme 1 Depicts the synthesis of β-(carboxyalkyl)ethyltributylphosphonium bromides (4-
8). Treatment of acrylic acid with tributylphosphine at room temperature in chloroform during 6 
hours yielded (87%) phosphabetaine 1. Alkylation of the starting phosphabetaine 1 – β-
tributylphosphonium ethylcarboxylate with alkyl halogenides (reflux for 14 hours in CH3Cl) 
gave the corresponding phosphonium bromides 4-8 with long alkyl chains. The yield was 52%-
72%.  
 
Biological results  
The synthesized compounds – a new class of bioactive nanomolecules – were screened for 
antibacterial and antifungal activity at 50µ/0.1mL concentration by using the cup-plate agar 
diffusion method, and standard drugs used were Chlorhexidine 9, Penicillin 10, and Griseofulvin 
11. The novel synthesized compounds 4-8 with long alkyl chains (n = 10, 12, 14, 16, 18) show 
maximal activity against pathogenic microorganisms. Starting phosphabetaine 1 and all 
phosphonium salts with shot alkyl chains, synthesized earlier
10,11
, were not active at all. 
Compound 6 and 7 were highly significant against tested bacteria as well as fungi. Our results 
are reported in Table 1. 
 Such a high biological activity of cationic biocides 4-8 we explain by their ability to be 
integrated into the lipid layers of biomembranes of pathogenic microflora eventually leading to 
the destruction of this last. To confirm this idea we studied the interaction mechanism of β-
(carboxyalkyl)ethyltriphenylphosphonium bromides – analogs of compounds 4-8 and phosphorus 
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analogs synthetic of biomembranes – with natural biological membranes (lecithin) using the 
model of Langmuir monolayers
11
. It was discovered that alkylated phosphabetaines interact with 
lecithin, by forming a pores, and thus deteriorating the membrane functions.  
 
 
Many years we thought that it is impossible to grow single crystals of oil products with 
long alkyl chains suitable for X-ray diffraction, but after five years we have a real chance to 
obtain the crystalline structure of the β-(carboxyhexadecyl)ethyltriphenylphosphonium bromide, 
which gave good quality crystals
3
 (Figure 1). 
CONCLUSIONS 
In conclusion, carboxylate phosphabetaines derivatives with alkyl chains of various 
lengths were synthesized in good yield, characterized by different spectral studies, and their 
antimicrobial activity has been evaluated. Compounds 6 and 7 demonstrated good inhibitions 
against all the strains tested comparable to Chlorhexidine, Penicillin and Griseofulvin as positive 
standard. So, it may be concluded from our results that the synthesized compounds are potent 
nanoantimicrobial agents against pathogenic bacteria and fungi. 
 
EXPERIMENTAL 
 Chemistry 
Materials and Methods 
All chemicals purchased from Sigma-Aldrich were reagent grade and used without 
purification. Analytical data were obtained from Perkin Elmer 2400 LS. And were found within 
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+ 0.4% of the theoretical values. IR spectra were taken on a spectrophotometer Specord 251R in 
the range 400-3700 cm
-1
 from mulls in mineral oil between KBr plates. 
1
H NMR (D2O) and 
31
P 
NMR (DMSO-d6) spectra were determined on a Bruker Avance digital spectrometer 400.13 
MHz. Chemical shifts were determined with respect to external reference, 85% H3PO4. The 
purity and thermal stability of crystal compounds were determined by simultaneous TG/DSC 
analysis on a NETZSCH STA 449C instrument (temperature range 20-400
o
C, heating rate 10 
deg/min, argon atmosphere). 
Synthesis of tributyl-(3-alkoxy-3-oxopropyl)-phosphonium bromides (4-8)  
General Procedure. A mixture of equimolar quantities of 3-(tributylphosphonio) propanoate 1 
(0.01 mol) and appropriate alkyl halogenides (0.01 mol) was refluxed in dry chloroform (75 ml) 
for 1 h. Excess of solvent was removed under reduced pressure. The resulting salts 4-8 were 
obtained as yellow oils and purified by diethyl ether from starting reagents.  
Preparation of tributyl-(3-decyloxy-3-oxopropyl)-phosphonium bromide (4). Yield 67%. 
IR (cm
-1
): 1720, 1125. 
1
H NMR (D2O 400.13 MHz): 0.78-0.93 (m, 12H, 4Me), 1.23-1.45 (m, 
26H, 13CH2), 1.58-1.65 (m, 2H, OCCH2), 2.35-2.41 (m, 2H, PCCH2), 2.48-2.87 (m, 8H, PCH2), 
4.13-4.23 (m, 2H, OCH2). 
31
P NMR (DMSO-d6, 161.9 MHz): 35.4. Anal (%) Calc. for 
C25H52BrO2P: C, 60.61; H 10.51. Found: C, 59.97; H, 10.73. (FW=494.9). 
Preparation of tributyl-(3-dodecyloxy-3-oxopropyl)-phosphonium bromide (5). Yield 60%. 
IR (cm
-1
): 1721, 1121. 
1
H NMR (D2O, 400.13 MHz): 0.75-0.97 (m, 12H, 4Me), 1.25-1.43 (m, 
30H, 15CH2), 1.60-1.69 (m, 2H, OCCH2), 2.31-2.41 (m, 2H, PCCH2), 2.47-2.85 (m, 8H, PCH2), 
4.11-4.25 (m, 2H, OCH2); 
31
P NMR (DMSO-d6, 161.9 MHz): 35.2. Anal (%) Calc. for 
C27H56BrO2P (FW=522.9): C 61.95; H 10.71. Found: C, 60.35; H, 10.39. 
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Preparation of tributyl-(3-tetradecyloxy-3-oxopropyl)phosphonium bromide (6). Yield 
52%. IR (cm
-1
): 1720, 1123. 
1
H NMR (D2O, 400.13 MHz): 0.81-0.91 (m, 12H, 4Me), 1.20-1.44 
(m, 34H, 17CH2), 1.57-1.67 (m, 2H, OCCH2), 2.37-2.43 (m, 2H, PCCH2), 2.45-2.97 (m, 8H, 
PCH2), 4.13-4.23 (m, 2H, OCH2); 
31
P NMR (DMSO-d6, 161.9 MHz): 35.5. Anal (%) Calc. for 
C29H60BrO2P: C, 63.16, H; 10.89. Found: C, 63.70; H, 10.13. (FW=550.9). 
Preparation of tributyl-(3-hexadecyloxy-3-oxopropyl)phosphonium bromide (7). Yield 
47%. IR (cm
-1
): 1719, 1120. 
1
H NMR (D2O, 400.13 MHz): 0.73-0.92 (m, 12H, 4Me), 1.13-1.45 
(m, 38H, 19CH2), 1.52-1.61 (m, 2H, OCCH2), 2.31-2.38 (m, 2H, PCCH2), 2.43-2.93 (m, 8H, 
PCH2), 4.13-4.23 (m, 2H, OCH2); 
31
P NMR (DMSO-d6, 161.9 MHz): 35.0. Anal (%) Calc. for 
C31H64BrO2P (FW=579): C, 64.25; H, 11.05. Found: C, 65.11; H, 11.66. 
Preparation of tributyl-(3-octadecyloxy-3-oxopropyl)phosphonium bromide (8). Yield 
72%. IR (cm
-1
): 1720, 1125. 
1
H NMR (D2O, 400.13 MHz): 0.77-0.97 (m, 12H, 4Me), 1.19-1.47 
(m, 42H, 21CH2), 1.59-1.65 (m, 2H, OCCH2), 2.33-2.39 (m, 2H, PCCH2), 2.45-2.86 (m, 8H, 
PCH2), 4.13-4.23 (m, 2H, OCH2); 
31
P NMR (DMSO-d6, 161.9 MHz): 35.3. Anal (%) Calc. for 
C33H68BrO2P (FW=606.9): C, 65.24; H, 11.20; found C, 65.87; H, 11.11. 
Biological results 
The antimicrobial activity of the newly synthesized compounds was determined in vitro 
using the agar disk-diffusion method using Mueller-Hilton agar medium against a variety of 
pathogenic microorganisms: Staphylococcus aureus (ATCC 29213) (Gram-positive bacteria), 
Escherichia coli (ATCC 25922), Pseudomonas aeruginoza (ATCC 27853), Bacillus cereus 
(ATCC 11778) and Proteus mirabilis (ATCC 12453) (Gram-negative bacteria) and fungus 
Candida albicans (ATCC 885-653). The inhibition zones of the tested compounds were 
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measured after 24-48 h incubation at 37
o
C for bacteria and after 5 days of incubation at 28
o
C for 
fungi. Penicillin (Sigma-Aldrich) and Chlorhexidine (Sigma-Aldrich) were used as reference 
drug for bacteria, whereas Griseofulvin (Sigma-Aldrich) was used as reference drug for fungi. 
Every experiment in the antibacterial and antifungal assay was replicated twice. For the 
antibacterial and antifungal activity, the compounds were dissolved in dimethylsulfoxide 
(DMSO). 
The antifungal activity was carried out by using cup-plate method using cup-plate method 
using Sabouraud’s agar medium. Fungal strains used were Candida albicans (ATCC 885-653) 
with incubation period of 48 hours at temperature 28
o
C. The standard drug used was 
Griseofulvin (50 µg/0.1 mL) and the test compounds at concentration of 50 µg/0.1 mL by using 
dimethyl sulfoxide (DMSO). 
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Table 1. Antimicrobial activity of the newly synthesized compounds and the control drugs  
(50 μg/0.1 mL) 
Zone of inhibition (mm) 
n Compound Staphyloc
occus 
aureus 
Escheri
chia 
coli 
Pseudom
onas 
aerugino
sa 
Bacill
us 
cereus 
Prote
us 
mirab
ilis 
Candi
da 
albica
ns 
4 Bu3PCH2CH2COOC10H21Br  
16 17 9 14 13 25 
5 Bu3PCH2CH2COOC12H25Br  
21 11.5 14 11 15 23.5 
6 Bu3PCH2CH2COOC14H29Br  
26 20 15 15 17.5 31 
7 Bu3PCH2CH2COOC16H33Br  
27.5 21 17 17.5 21 37 
8 Bu3PCH2CH2COOC18H37Br  
14 13 11 8 14 20.5 
9 Chlorhexidine 16 15 13 13 15 14 
1
0 
Penicillin 20 17 11 7 10 - 
1
1 
Griseofulvin - - - - - 20 
 
n: Compound number 
All tests were performed in triplicate. Zone of inhibition 22 to 31: highly significant, between 15 
to 21 mm: less significant, below 14 mm: poor active. 
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Figura 1. Molecular structure of the asymmetric unit of the Ph3PCH2CH2C(O)OC16H33 in crystal. 
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4-8
R = C10H21    (4)
R = C12H25    (5)
R = C14H29    (6)
CH2=CHCOOH
Bu3P, CHCl3
20oC, 6 h
Bu3PCH2CH2COO
CnH2n+1 Br, CHCl3
reflux, 14 h
Bu3PCH2CH2COORBr
R = C16H33    (7)
R = C18H37    (8)
1
 
 
Scheme 1. Synthetic routes of β-(carboxyalkyl)ethyltributylphosphonium bromides 4-8; reagents 
and conditions. 
 
 
